Protective role of the Atg8 1 homologue Gabarapl1 in regulating cardiomyocyte glycophagy in diabetic heart disease
Mellor, K. M.; Varma, U.; Koutsifeli, P.; Curl, C. L.; Janssens, J. V.; Daniels, L. J.; Bernasochi, G. B.; Raaijmakers, A. J. A.; Benson, V. L.; Chan, E. J.; Annandale, M.; Li, X.; Nursalim, Y.; Ip, W. T. K.; Taylor, D. J.; Raedschelders, K.; Stotland, A.; Robinson, A. E.; Mills, R. J.; Lamberts, R. R.; Powell, K. L.; O'Brien, T. J.; Katare, R.; Chandramouli, C.; Ritchie, R. H.; Lim, S. Y.; Parton, R. G.; Hu, X.; Bell, J. R.; Porrello, E. R.; Hudson, J. E.; Xiao, R.-P.; Van Eyk, J. E.; Gottlieb, R. A.; Delbridge, L. M. D.
Show abstract
Diabetic heart disease is highly prevalent and characterized by diastolic dysfunction. The mechanisms of diabetic heart disease are poorly understood and no targeted therapies are available. Here we show that the diabetic myocardium (type 1 and type 2) is characterized by marked glycogen elevation and ectopic cellular localization - a paradoxical metabolic pathology given suppressed cardiomyocyte glucose uptake in diabetes. We demonstrate involvement of a glycogen-selective autophagy pathway ( glycophagy) defect in mediating this pathology. Genetically manipulated deficiency of Gabarapl1, an Atg8 autophagy homologue, induces cardiac glycogen accumulation and diastolic dysfunction. Stbd1, the Gabarapl1 cognate autophagosome partner is identified as a unique component of the early glycoproteome response to hyperglycemia in cardiac, but not skeletal muscle. Cardiac-targeted in vivo Gabarapl1 gene delivery normalizes glycogen levels, diastolic function and cardiomyocyte mechanics. These findings reveal that cardiac glycophagy is a key metabolic homeostatic process perturbed in diabetes that can be remediated by Gabarapl1 intervention.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Glycaemic variability underlies myocyte dysfunction and myocardial injury risk in diabetes 95%
- Cardiomyocyte Contractile Impairment in Heart Failure Results from Reduced BAG3-mediated Sarcomeric Protein Turnover 95%
- Mitochondrial CaMKII causes metabolic reprogramming, energetic insufficiency, and dilated cardiomyopathy 95%
Similar papers in this journal
- Target deconvolution of an insulin hypersecretion-inducer acting through VDAC1 with a distinct transcriptomic signature in beta-cells 94%
- Pervasive nuclear envelope ruptures precede ECM signaling and disease onset without activating cGAS-STING in Lamin-cardiomyopathy mice 94%
- Chronic intermittent fasting impairs β-cell maturation and function in adolescent mice 94%
Similar papers in this journal
Similar papers in this journal
- Targeted glycophagy ATG8 therapy reverses diabetic heart disease in mice and in human engineered cardiac tissues 97%
- Immunomodulation by AZD1656 reverses cardiac dysfunction, metabolic remodelling and reduces infarct size in type 2 diabetic cardiomyopathy 96%
- Glucocorticoid Receptor ablation promotes cardiac regeneration by hampering cardiomyocyte terminal differentiation 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.